Aug 25 (Reuters) - Regis Healthcare Ltd (REG) :
- FY 2017 EBITDA is anticipated to be in excess of 15% more than normalised FY
2016
- The company is expected to have higher depreciation charge than in FY 2016
- Says total capex spend is anticipated to be in the order of $160M in FY 2017
- * (( )) (([email protected]))
Aug 25 (Reuters) - Regis Healthcare Ltd (REG) : FY 2017 EBITDA...
Add REG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.70 |
Change
0.260(4.04%) |
Mkt cap ! $1.755B | |||
| Open | High | Low | Value | Volume |
| $6.49 | $6.81 | $6.48 | $4.017M | 598.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4399 | $6.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.72 | 2498 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| REG (ASX) Chart |
